Sort by
Refine Your Search
-
Listed
-
Field
-
priority. For more information about Dr. Vu Ngo’s research, please visit here . As a successful candidate, you will: Plan, design, and execute experiments independently and in collaboration with lab members
-
are working on this may be the perfect opportunity: 1. Development of cell-free DNA (mutation and methylation), RNA, and exosomal-based liquid assays for early cancer detection, prognosis, and predictive
-
following things we are working on this may be the perfect opportunity: 1. Development of cell-free DNA (mutation and methylation), RNA, and exosomal-based liquid assays for early cancer detection, prognosis
-
at risk of developing type 1 or type 2 diabetes. The Thurmond Lab is also examining Doc2b as a potential biomarker for diabetes. If this protein can help us detect early diabetic changes, patients can
-
tools to identify novel signaling pathways to develop new targets for drug discovery. Our research interests include: 1) Liver-gut and microbiota crosstalk as metabolic mediators in regulating both normal
-
pioneering the development of neural stem cell (NSC) and extracellular vesicle (EV)-based therapies for neurodegenerative conditions, including traumatic brain injury (TBI), chemotherapy-related cognitive
-
drug development, with strong potential for publication in high-impact journals. Our research aims to uncover fundamental mechanisms of leukemogenesis and solid tumor progression, with a particular
-
information about Dr. Vu Ngo’s research, please visit here . As a successful candidate, you will: Plan, design, and execute experiments independently and in collaboration with lab members. Generate data
-
to vaccine development utilizing viral vectors to contribute to an effort in developing neoantigen expressing vaccines for clinical investigations. The position is available as part of a multi-disciplinary
-
of Hope. This role offers an exciting opportunity to investigate immune checkpoint signaling within the tumor microenvironment and contribute to the development of novel anticancer therapies